PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF PYRIDOSTIGMINE IN MAN

被引：83

作者：

AQUILONIUS, SM

ECKERNAS, SA

HARTVIG, P

LINDSTROM, B

OSTERMAN, PO

机构：

[1] UNIV UPPSALA HOSP,DEPT PHARM,S-75014 UPPSALA,SWEDEN

[2] NATL BOARD HLTH & WELF,DEPT DRUGS,UPPSALA,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1980年 / 18卷 / 05期

关键词：

D O I：

10.1007/BF00636797

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：423 / 428

页数：6

相关论文

共 13 条

[1] PHARMACOKINETIC STUDY OF NEOSTIGMINE IN MAN USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY
AQUILONIUS, SM
ECKERNAS, SA
HARTVIG, P
HULTMAN, J
LINDSTROM, B
OSTERMAN, PO
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (05) : 367 - 371
[2] BEERMANN B, 1972, EUR J CLIN PHARMACOL, V5, P83
[3] CALVEY TN, 1977, CLIN PHARMACOL THER, V21, P187
[4] QUANTITATIVE GAS-LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF NEOSTIGMINE AND PYRIDOSTIGMINE IN HUMAN-PLASMA
CHAN, K
WILLIAMS, NE
BATY, JD
CALVEY, TN
[J]. JOURNAL OF CHROMATOGRAPHY, 1976, 120 (02): : 349 - 358
[5] RENAL CLEARANCE OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS
CHAN, K
CALVEY, TN
[J]. EUROPEAN NEUROLOGY, 1977, 16 (1-6) : 69 - 72
[6] CHAN K, 1978, CLIN PHARMACOL THER, V22, P596
[7] MALABSORPTION OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS
COHAN, SL
DRETCHEN, KL
NEAL, A
[J]. NEUROLOGY, 1977, 27 (03) : 299 - 301
[8] PHARMACOKINETICS OF PYRIDOSTIGMINE
COHAN, SL
POHLMANN, JLW
MIKSZEWSKI, J
ODOHERTY, DS
[J]. NEUROLOGY, 1976, 26 (06) : 536 - 539
[9] EFFECT OF CHRONIC PYRIDOSTIGMINE ADMINISTRATION ON PYRIDOSTIGMINE-C-14 METABOLISM IN MYASTHENIA GRAVIS
KORNFELD, P
WOLF, RL
SAMUELS, AJ
OSSERMAN, KE
[J]. NEUROLOGY, 1971, 21 (05) : 550 - &
[10] METABOLISM OF C-14-LABELED PYRIDOSTIGMINE IN MYASTHENIA GRAVIS - EVIDENCE FOR MULTIPLE METABOLITES
KORNFELD, P
SAMUELS, AJ
WOLF, RL
OSSERMAN, KE
[J]. NEUROLOGY, 1970, 20 (07) : 634 - &